1,670 Shares in Teladoc Health, Inc. (NYSE:TDOC) Bought by RIA Advisory Group LLC

RIA Advisory Group LLC acquired a new position in shares of Teladoc Health, Inc. (NYSE:TDOC) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 1,670 shares of the health services provider’s stock, valued at approximately $36,000.

A number of other hedge funds have also made changes to their positions in the stock. Acadian Asset Management LLC acquired a new position in shares of Teladoc Health during the first quarter valued at about $27,000. Covestor Ltd raised its holdings in Teladoc Health by 1,711.7% in the first quarter. Covestor Ltd now owns 1,087 shares of the health services provider’s stock worth $78,000 after purchasing an additional 1,027 shares during the period. Geneos Wealth Management Inc. increased its position in shares of Teladoc Health by 215.5% during the first quarter. Geneos Wealth Management Inc. now owns 1,161 shares of the health services provider’s stock worth $83,000 after acquiring an additional 793 shares in the last quarter. Dark Forest Capital Management LP increased its position in shares of Teladoc Health by 408.2% during the first quarter. Dark Forest Capital Management LP now owns 1,245 shares of the health services provider’s stock worth $32,000 after acquiring an additional 1,000 shares in the last quarter. Finally, Tyler Stone Wealth Management bought a new position in Teladoc Health in the second quarter valued at $33,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

Analysts Set New Price Targets

TDOC has been the subject of several analyst reports. Barclays dropped their price objective on shares of Teladoc Health from $26.00 to $25.00 and set an “overweight” rating for the company in a research note on Wednesday, February 21st. SVB Leerink started coverage on shares of Teladoc Health in a report on Monday, February 26th. They set a “market perform” rating and a $17.00 price objective on the stock. DA Davidson dropped their price objective on shares of Teladoc Health from $22.00 to $18.00 and set a “neutral” rating on the stock in a report on Wednesday, February 21st. Royal Bank of Canada lowered their target price on shares of Teladoc Health from $30.00 to $25.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 21st. Finally, Piper Sandler cut their price target on shares of Teladoc Health from $30.00 to $25.00 and set an “overweight” rating on the stock in a report on Wednesday, February 21st. Eight investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $22.23.

Teladoc Health Stock Performance

Shares of TDOC stock opened at $12.98 on Friday. The company has a current ratio of 3.54, a quick ratio of 3.47 and a debt-to-equity ratio of 0.66. Teladoc Health, Inc. has a 12-month low of $12.85 and a 12-month high of $30.41. The business’s 50 day moving average is $15.59 and its two-hundred day moving average is $17.91.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Tuesday, February 20th. The health services provider reported ($0.17) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.05. The firm had revenue of $660.50 million during the quarter, compared to analysts’ expectations of $670.79 million. Teladoc Health had a negative net margin of 8.47% and a negative return on equity of 9.22%. The firm’s revenue was up 3.6% on a year-over-year basis. During the same period in the prior year, the company earned ($0.23) EPS. On average, equities analysts expect that Teladoc Health, Inc. will post -1.07 earnings per share for the current fiscal year.

Insider Activity at Teladoc Health

In other Teladoc Health news, insider Laizer Kornwasser sold 7,882 shares of Teladoc Health stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $19.18, for a total value of $151,176.76. Following the transaction, the insider now owns 57,223 shares in the company, valued at $1,097,537.14. The transaction was disclosed in a document filed with the SEC, which is available at this link. In related news, insider Arnnon Geshuri sold 7,500 shares of the company’s stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $15.06, for a total value of $112,950.00. Following the sale, the insider now owns 38,470 shares of the company’s stock, valued at $579,358.20. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Laizer Kornwasser sold 7,882 shares of the company’s stock in a transaction dated Friday, February 2nd. The stock was sold at an average price of $19.18, for a total transaction of $151,176.76. Following the sale, the insider now directly owns 57,223 shares in the company, valued at $1,097,537.14. The disclosure for this sale can be found here. Insiders have sold 135,441 shares of company stock worth $2,038,251 over the last quarter. 1.63% of the stock is currently owned by company insiders.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.